Brain Cancer Trial, Recruiting NCT04816006 Sponsor: Mayo Clinic Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT04816006
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 or older at the time of joining the trial
  • People whose first and only primary breast cancer diagnosis was stage I to IIIa (not stage 0 and not spread to other parts of the body)
  • People who finished their main cancer treatments (such as surgery, chemotherapy, and/or radiation therapy) between 3 and 36 months before joining the trial
  • People who have not been doing much regular exercise — specifically, those who report doing no more than 90 minutes per week of moderate aerobic exercise in the past 6 months
  • People who are able to complete study assessments on their own or with some assistance
  • People who are able to walk without assistance or mobility devices
  • People who are able to provide a medical records release so their eligibility can be confirmed
  • People whose cognitive (thinking and memory) function meets the required score on a telephone screening test (score above 21 on the TICS-M)
  • People whose doctor has given clearance for them to take part in an exercise program (people with certain heart-related conditions may need clearance specifically from a heart specialist)
  • People who are willing and able to travel regularly to study locations for sessions and data collection
  • People who are willing to return to the enrolling location for follow-up visits
  • People who are willing to be randomly assigned to either an exercise group or a health education group
  • People who are able to wear and regularly charge and sync an activity tracker throughout the study

Who may not be able to join:

  • People diagnosed with stage 0 breast cancer or breast cancer that has spread to other parts of the body (metastatic disease)
  • People who are currently receiving chemotherapy or radiation therapy, or who finished these treatments less than 3 months ago, or more than 36 months ago
  • People who have a second cancer diagnosis (not including certain non-invasive skin cancers)
  • People who have planned surgery during the period when the trial program would be taking place
  • People who have a history of stroke, mini-stroke (transient ischemic attack), other neurological conditions, or brain surgery that involved removing brain tissue
  • People whose thinking and memory score on the telephone screening test is 21 or below
  • People who have conditions that make an MRI scan unsafe, in line with the study site's radiology safety guidelines
  • People whose MRI brain scan shows results that a doctor advises need further medical follow-up
  • People who are already enrolled in another physical activity program
  • People whose baseline exercise test results (heart rhythm or blood pressure) raise concerns and who are unable to get re-clearance from a doctor
  • People who are unwilling to complete all study requirements
  • People who are unwilling to be randomly placed into either the exercise group or the health education group
  • People who are unable or unwilling to wear and regularly charge and sync an activity tracker during the study
  • People who are unable to travel regularly to study locations
  • People who are unwilling to return to the enrolling location for follow-up visits

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Diane K. Ehlers, Ph.D., Mayo Clinic

Phone: 480-574-4052

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
22 February 2024
Est. completion
31 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in inhibitory control; Change in cognitive flexibility; Change in executive function processing; Change in short-term memory; Change in verbal memory; Change in working memory; Change in brain volume; Change in white matter integrity; Change in resting state functional connectivity; Change in self-reported cognitive function; Reach; Adoption; Change in Cardiorespiratory Fitness; Change in Cancer-related Fatigue; Implementation; Maintenance; Change in processing speed; Change in attention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov